Clinical Trial Update: A Single Dose of Pembrolizumab in HIV-Infected People [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of a single dose of pembrolizumab in people living with HIV infection. The trial was terminated, and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Human Immunodeficiency Virus | Phase 1 | Status: TERMINATED | Results posted: 2025-01-17